Prime Medicine

Performance

About Prime Medicine

Prime Medicine is a biotechnology company focused on developing and applying Prime Editing, a next-generation gene editing platform that aims to directly address genetic causes of disease. The company describes its approach as a DNA word processor that searches and replaces disease-causing genetic sequences at precise genomic locations without double-strand breaks, with the goal of providing long-lasting therapeutic benefits. Its work spans research, science, and clinical programs intended to transform how genetic diseases are treated, with applications across multiple organ systems and diseases. Prime Medicine is headquartered in the United States and communicates a global research and development focus with partnerships and investor relations highlighting its pipeline and scientific publications.